NCT02975102 - A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions

Dry Eye

Interventions

DEVICE

CBL-101 Eye Drops

CBL-101 Eye Drops 3 to 6 times per day for 3 months.

DEVICE

Vismed® Multi Eye Drops

Vismed® Multi 3 to 6 times per day for 3 months.

Trial Locations (2)

Pr Mortemousque private office, Bordeaux

Dr. Nyst private office, Huy